United StatesOndansetron ODT Tablets, USP 4 mg, 1x10 unit dose tablets (manufactured by Glenmark Pharmaceuticals Limited, repackaged by Preferred Pharmaceuticals, NDC 68788-8666-01), lots J1325J and I1725P, exp. 4/30/2027 (575 1x10 foil blister packs sold nationwide in the USA) are being recalled. The recall was issued because the blister packs are not fully sealed and tablets have been falling out.
What's being recalled
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Recalling firm: Preferred Pharmaceuticals, Inc., Anaheim, CA, United States.
How to identify it
Lot: J1325J, I1725P, EXP Date: 4/30/2027.
The hazard
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Natinowide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)